Showing results (31-40 of 44) with videos related to
Sort By:
Pageof 5
European Journal of Neurology|September 24, 2004
Delayed administration may improve entacapone effects in parkinsonian patients non-responding to the drugL Brusa, A Bassi, G Lunardi, et al.Parkinsonism & Related Disorders|March 14, 2008
Deep brain stimulation of CM/PF of thalamus could be the new elective target for tremor in advanced Parkinson's Disease?A Peppe, A Gasbarra, A Stefani, et al.Journal of Neural Transmission (Vienna, Austria : 1996)|March 27, 2003
Pramipexole in comparison to l-dopa: a neuropsychological studyL Brusa, A Bassi, A Stefani, et al.Electroencephalography and Clinical Neurophysiology|September 19, 1998
Does pattern electroretinogram spatial tuning alteration in Parkinson's disease depend on motor disturbances or retinal dopaminergic loss?A Peppe, P Stanzione, M Pierantozzi, et al.Rivista Di Neurologia|July 1, 1991
[Miller Fisher syndrome: review of the literature and presentation of 2 cases]C Scoppetta, M Fontana, R Quadrini, et al.European Journal of Neurology|January 11, 2002
Bilateral GPi DBS is useful to reduce abnormal involuntary movements in advanced Parkinson's disease patients, but its action is related to modality and site of stimulationA Peppe, M Pierantozzi, M G Altibrandi, et al.Brain and Language|July 31, 2012
Effect of levodopa on both verbal and motor representations of action in Parkinson's disease: a fMRI studyP Péran, F Nemmi, D Méligne, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|November 26, 1999
The effect of deep brain stimulation on the frontal N30 component of somatosensory evoked potentials in advanced Parkinson's disease patientsM Pierantozzi, P Mazzone, A Bassi, et al.Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology|January 22, 2002
Subdyskinetic apomorphine responses in globus pallidus and subthalamus of parkinsonian patients: lack of clear evidence for the 'indirect pathway'A Stefani, A Bassi, P Mazzone, et al.Cell Death & Disease|May 6, 2011
The clinical efficacy of L-DOPA and STN-DBS share a common marker: reduced GABA content in the motor thalamusA Stefani, E Fedele, J Vitek, et al.Pageof 5